Contraception with Chlormadinone Acetate in Woman with Previous Contraceptive Jaundice
- 17 January 1970
- Vol. 1 (5689) , 152-153
- https://doi.org/10.1136/bmj.1.5689.152
Abstract
The oral contraceptive chlormadinone acetate has been given for eight months to a woman who had developed jaundice during four pregnancies, and twice while taking a combined contraceptive pill. No side-effects or changes in liver function were observed. This is further evidence that progestogens used for contraception, and in particular those derived from hydroxyprogesterone, are less hepatotoxic than the oestrogenic components.Keywords
This publication has 13 references indexed in Scilit:
- LOW-DOSE CONTINUOUS CHLORMADINONE ACETATE AS AN ORAL CONTRACEPTIVE: A Clinical TrialThe Lancet, 1969
- CHLORMADINONE ACETATE AS ORAL CONTRACEPTIVE: A Clinical TrialThe Lancet, 1969
- The effect of estrogen on bile formation in the ratJournal of Clinical Investigation, 1969
- Developments in jaundicePostgraduate Medical Journal, 1969
- Norethisterone jaundice in two sisters.BMJ, 1968
- Liver Dysfunction with Mestranol but not with Norethynodrel in a Patient with Enovid®-Induced JaundiceAnnals of Internal Medicine, 1968
- The metabolism of megestrol acetate (17α-acetoxy-6-methylpregna-4,6-diene-3,20-dione) in womenSteroids, 1968
- Idiopathic Cholestasis of PregnancyNew England Journal of Medicine, 1967
- Hepatic Effects of Oral ContraceptivesNew England Journal of Medicine, 1967
- Urinary Œstrogen Metabolites of 19-Norethisterone and its Esters [Summary].1960